Scientists and analysts express concern that the newly appointed members—which include known anti-vaxxers—could relitigate ...

The biopharma job market failed to turn around in May, but employers were still hiring, especially in Indiana and California, ...

In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

The rehired staff, who number around 460, work with the CDC’s viral disease prevention efforts and sexual health testing labs ...

Looking for a new opportunity in New Jersey? These nine companies have open roles that could be a great fit for you.

The eight new committee members replace the 17 Kennedy removed earlier this week. In “repopulating” the committee, the HHS ...

After enduring multiple rounds of layoffs last year, Genentech’s employees are facing more uncertainty as the Roche unit lets ...

FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...

Instead of homing in on PSMA—currently the most validated target in prostate cancer—BMS and Philochem will instead ...

Gene therapies have ridden investor mania to huge valuations but commercialization challenges have pushed market caps to the ...

The company’s intein-based technology is initially aimed at Stargardt disease, a type of macular degeneration.

The American Medical Association is also urging an “immediate reversal” of the HHS Secretary's decision to oust all 17 ...